Avadel Pharmaceuticals Plc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2025 to a ratio of 6.27, this represents a new company high. This is a clear indication for improving liquidity at Avadel Pharmaceuticals Plc's clients. Average receivable collection period, for the Avadel Pharmaceuticals Plc in Sep 30 2025 quarter, has decreased to 58 days, compared to 63 days, in the Jun 30 2025 quarter.

If we take a look into Healthcare sector 279 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2025 from 523 to 2193.

What is Receivable Turnover Ratio?
What is Avadel Pharmaceuticals Plc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AVDL Receivables Turnover Ratio	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Receivable Change	14.4 %	21.73 %	83.24 %	446.51 %	1990.25 %
Y / Y Revenue Change	55.34 %	66.43 %	94.83 %	635.64 %	3233.56 %
Receivable Turnover Ratio (TTM)	6.27	5.77	5.31	5.31	5
AVDL's Total Ranking	# 2193	# 523	# 634	# 291	# 525
Accounts Receivable average collection period days	58	63	69	69	73
Seq. Receivable Change	4.46 %	-2.28 %	21.95 %	-8.1 %	11.16 %
Seq. Revenue Change	14.32 %	30.48 %	0.65 %	3.47 %	22.48 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 83
Healthcare Sector	# 280
Overall Market	# 2193

Receivable Turnover Ratio Statistics
High	Average	Low
6.27	5.38	4.74
(Sep 30 2025)		(Jun 30 2024)

AVDL Company Profile • Back to AVDL Efficiency Comparisons • Compare AVDL Receivables Turnover Ratio to its Competitors

Financial Statements
Avadel Pharmaceuticals Plc's Accounts Receivable	$ 42 Millions	Visit AVDL's Balance sheet
Avadel Pharmaceuticals Plc's Sales TTM	$ 249 Millions	Visit AVDL's Income Statement
Sources of AVDL's Revenues		Visit AVDL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AVDL's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AVDL's Growth Rates	AVDL's Roa	AVDL's Inventory Turnover Ratio	AVDL's Dividend Comparisons
AVDL's Profitability Ratios	AVDL's Roi	AVDL's Asset Turnover Ratio	AVDL's Dividend Growth
AVDL's Valuation Ratios	AVDL's Roe	AVDL's Financial Strength Ratios	AVDL's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2025	Receivable at quarter ending Sep 30 2025
Talkspace Inc	16.12	$ 214.505 Millions	$ 13.310 Millions
Voyager Therapeutics Inc	15.68	$ 31.316 Millions	$ 1.997 Millions
Amneal Pharmaceuticals Inc	15.06	$ 2,933.636 Millions	$ 194.776 Millions
Xoma Royalty Corporation	14.75	$ 47.106 Millions	$ 3.193 Millions
Mannkind Corporation	14.73	$ 313.787 Millions	$ 21.307 Millions
Milestone Scientific Inc	14.65	$ 8.734 Millions	$ 0.596 Millions
Kiniksa Pharmaceuticals International Plc	14.46	$ 597.973 Millions	$ 41.360 Millions
Qhslab Inc	13.95	$ 2.614 Millions	$ 0.187 Millions
Vivos Therapeutics Inc	13.55	$ 16.653 Millions	$ 1.229 Millions
Clene Inc	13.38	$ 0.214 Millions	$ 0.016 Millions
Inmed Pharmaceuticals Inc	13.34	$ 4.798 Millions	$ 0.360 Millions
Ensysce Biosciences Inc	13.24	$ 4.488 Millions	$ 0.339 Millions
China Pharma Holdings Inc	13.14	$ 4.052 Millions	$ 0.308 Millions
Icu Medical Inc	12.80	$ 2,319.576 Millions	$ 181.198 Millions
Ptc Therapeutics inc	12.76	$ 1,779.150 Millions	$ 139.440 Millions
Rosecliff Acquisition Corp I	12.64	$ 24.634 Millions	$ 1.949 Millions
Sutro Biopharma Inc	12.39	$ 105.646 Millions	$ 8.525 Millions
Newamsterdam Pharma Company N v	12.34	$ 35.243 Millions	$ 2.856 Millions
Escalon Medical Corp	12.32	$ 11.940 Millions	$ 0.969 Millions
Scorpius Holdings inc	12.30	$ 1.716 Millions	$ 0.140 Millions
Harvard Apparatus Regenerative Technology Inc	12.23	$ 0.743 Millions	$ 0.061 Millions
Cytokinetics Incorporated	12.08	$ 87.211 Millions	$ 7.220 Millions
Option Care Health Inc	12.01	$ 5,532.505 Millions	$ 460.534 Millions
Corcept Therapeutics Inc	11.86	$ 741.172 Millions	$ 62.498 Millions
Ss Innovations International Inc	11.86	$ 40.946 Millions	$ 3.454 Millions
Chemed Corporation	11.80	$ 2,530.634 Millions	$ 214.372 Millions
Ethema Health Corporation	11.72	$ 15.420 Millions	$ 1.315 Millions
Skinhealth Systems Inc	11.55	$ 301.672 Millions	$ 26.128 Millions
Nrc Health	11.53	$ 139.104 Millions	$ 12.066 Millions
Teladoc Health Inc	11.45	$ 2,528.199 Millions	$ 220.826 Millions

Date modified: 2026-09-08T15:11:34+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.